The emerging treatment of the medication represents a exciting development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and glucose-dependent https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment